Douglas Fambrough - Net Worth and Insider Trading
Douglas Fambrough Net Worth
The estimated net worth of Douglas Fambrough is at least $2 Million dollars as of 2024-11-05. Douglas Fambrough is the President and CEO of Dicerna Pharmaceuticals Inc and owns about 43,164 shares of Dicerna Pharmaceuticals Inc (DRNA) stock worth over $2 Million. Details can be seen in Douglas Fambrough's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Douglas Fambrough has not made any transactions after 2021-08-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Douglas Fambrough
Douglas Fambrough Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Douglas Fambrough owns 2 companies in total, including Dicerna Pharmaceuticals Inc (DRNA) , and Oncorus Inc (ONCR) .
Click here to see the complete history of Douglas Fambrough’s form 4 insider trades.
Insider Ownership Summary of Douglas Fambrough
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DRNA | Dicerna Pharmaceuticals Inc | 2021-08-10 | director & President and CEO |
| ONCR | Oncorus Inc | 2022-06-22 | director |
Douglas Fambrough Latest Holdings Summary
Douglas Fambrough currently owns a total of 1 stock. Douglas Fambrough owns 43,164 shares of Dicerna Pharmaceuticals Inc (DRNA) as of August 10, 2021, with a value of $2 Million.
Latest Holdings of Douglas Fambrough
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DRNA | Dicerna Pharmaceuticals Inc | 2021-08-10 | 43,164 | 38.22 | 1,649,728 |
Holding Weightings of Douglas Fambrough
Douglas Fambrough Form 4 Trading Tracker
According to the SEC Form 4 filings, Douglas Fambrough has made a total of 3 transactions in Dicerna Pharmaceuticals Inc (DRNA) over the past 5 years, including 2 buys and 1 sells. The most-recent trade in Dicerna Pharmaceuticals Inc is the acquisition of 5,000 shares on August 10, 2021, which cost Douglas Fambrough around $110,500.
Insider Trading History of Douglas Fambrough
- 1
Douglas Fambrough Trading Performance
GuruFocus tracks the stock performance after each of Douglas Fambrough's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Douglas Fambrough is 8.42%. GuruFocus also compares Douglas Fambrough's trading performance to market benchmark return within the same time period. The performance of stocks bought by Douglas Fambrough within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Douglas Fambrough's insider trading performs compared to the benchmark.
Performance of Douglas Fambrough
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.63 | | | | | |
| Relative Return to S&P 500(%) | -5.66 | | | | | |
Douglas Fambrough Ownership Network
Ownership Network List of Douglas Fambrough
Ownership Network Relation of Douglas Fambrough
Douglas Fambrough Owned Company Details
What does Dicerna Pharmaceuticals Inc do?
Who are the key executives at Dicerna Pharmaceuticals Inc?
Douglas Fambrough is the director & President and CEO of Dicerna Pharmaceuticals Inc. Other key executives at Dicerna Pharmaceuticals Inc include See Remarks Bob D Brown , EVP & Chief Medical Officer Shreeram Aradhye , and Chief Operating Officer & EVP James B Weissman .
Dicerna Pharmaceuticals Inc (DRNA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Dicerna Pharmaceuticals Inc (DRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Dicerna Pharmaceuticals Inc (DRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Dicerna Pharmaceuticals Inc (DRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dicerna Pharmaceuticals Inc Insider Transactions
Douglas Fambrough Mailing Address
Above is the net worth, insider trading, and ownership report for Douglas Fambrough. You might contact Douglas Fambrough via mailing address: C/o Dicerna Pharmaceuticals, Inc., 75 Hayden Avenue, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
